These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24871332)

  • 1. Dual-energy computed tomography for the assessment of early treatment effects of regorafenib in a preclinical tumor model: comparison with dynamic contrast-enhanced CT and conventional contrast-enhanced single-energy CT.
    Knobloch G; Jost G; Huppertz A; Hamm B; Pietsch H
    Eur Radiol; 2014 Aug; 24(8):1896-905. PubMed ID: 24871332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
    Jost G; Pietsch H; Grenacher L
    Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.
    Eschbach RS; Clevert DA; Hirner-Eppeneder H; Ingrisch M; Moser M; Schuster J; Tadros D; Schneider M; Kazmierczak PM; Reiser M; Cyran CC
    PLoS One; 2017; 12(1):e0169323. PubMed ID: 28060884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation.
    Cyran CC; Kazmierczak PM; Hirner H; Moser M; Ingrisch M; Havla L; Michels A; Eschbach R; Schwarz B; Reiser MF; Bruns CJ; Nikolaou K
    PLoS One; 2013; 8(9):e76009. PubMed ID: 24098755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
    Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
    Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Mulé S; Pigneur F; Quelever R; Tenenhaus A; Baranes L; Richard P; Tacher V; Herin E; Pasquier H; Ronot M; Rahmouni A; Vilgrain V; Luciani A
    Eur Radiol; 2018 May; 28(5):1977-1985. PubMed ID: 29168007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study.
    Gudmundsson E; Labby Z; Straus CM; Sensakovic WF; Li F; Rose B; Cunliffe A; Kindler HL; Armato SG
    Eur Radiol; 2019 Feb; 29(2):682-688. PubMed ID: 29967955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?
    Stiller W; Skornitzke S; Fritz F; Klauss M; Hansen J; Pahn G; Grenacher L; Kauczor HU
    Invest Radiol; 2015 Oct; 50(10):703-8. PubMed ID: 26039774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Efficacy of Dynamic Maneuver in Contrast-Enhanced Computed Tomography Compared With Conventional Contrast-Enhanced Computed Tomography in Imaging the Neck Region.
    B S; Sam A; Gunasekaran D; Muralidharan Y; Natarajan P
    Cureus; 2024 Jul; 16(7):e65074. PubMed ID: 39171018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-energy perfusion-CT of pancreatic adenocarcinoma.
    Klauss M; Stiller W; Pahn G; Fritz F; Kieser M; Werner J; Kauczor HU; Grenacher L
    Eur J Radiol; 2013 Feb; 82(2):208-14. PubMed ID: 23062281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of image quality and radiation dose of different pulmonary CTA protocols on a 128-slice CT: high-pitch dual source CT, dual energy CT and conventional spiral CT.
    De Zordo T; von Lutterotti K; Dejaco C; Soegner PF; Frank R; Aigner F; Klauser AS; Pechlaner C; Schoepf UJ; Jaschke WR; Feuchtner GM
    Eur Radiol; 2012 Feb; 22(2):279-86. PubMed ID: 21874569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.
    Ren Y; Fleischmann D; Foygel K; Molvin L; Lutz AM; Koong AC; Jeffrey RB; Tian L; Willmann JK
    Invest Radiol; 2012 Jan; 47(1):25-32. PubMed ID: 22178893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.
    Eschbach RS; Fendler WP; Kazmierczak PM; Hacker M; Rominger A; Carlsen J; Hirner-Eppeneder H; Schuster J; Moser M; Havla L; Schneider MJ; Ingrisch M; Spaeth L; Reiser MF; Nikolaou K; Cyran CC
    PLoS One; 2015; 10(2):e0115543. PubMed ID: 25668193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancer.
    Ng QS; Goh V; Milner J; Sundin J; Wellsted D; Saunders MI; Hoskin PJ
    Lung Cancer; 2010 Jul; 69(1):71-6. PubMed ID: 19781806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
    Lind JS; Meijerink MR; Dingemans AM; van Kuijk C; Ollers MC; de Ruysscher D; Postmus PE; Smit EF
    Eur Radiol; 2010 Dec; 20(12):2890-8. PubMed ID: 20625738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Deoxy-3'-
    Kim JE; Chae SY; Kim JH; Kim HJ; Kim TW; Kim KP; Kim SY; Lee JL; Oh SJ; Kim JS; Ryu JS; Moon DH; Hong YS
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1713-1722. PubMed ID: 31041456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-energy micro-CT functional imaging of primary lung cancer in mice using gold and iodine nanoparticle contrast agents: a validation study.
    Ashton JR; Clark DP; Moding EJ; Ghaghada K; Kirsch DG; West JL; Badea CT
    PLoS One; 2014; 9(2):e88129. PubMed ID: 24520351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib.
    Andersen IR; Olesen R; Boysen AK; Jensen LH; Mortensen FV; Nielsen DT; Rasmussen F
    Acta Radiol; 2019 Jul; 60(7):836-845. PubMed ID: 30348001
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of dual energy CT in differentiating between brain haemorrhage and contrast medium after mechanical revascularisation in acute ischaemic stroke.
    Tijssen MP; Hofman PA; Stadler AA; van Zwam W; de Graaf R; van Oostenbrugge RJ; Klotz E; Wildberger JE; Postma AA
    Eur Radiol; 2014 Apr; 24(4):834-40. PubMed ID: 24258277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.